These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39113723)

  • 1. Determination of the reference interval for urinary klotho to creatinine ratio of healthy dogs.
    Marečáková N; Kačírová J; Tóthová C; Maďari A; Maďar M; Farbáková J; Horňák S
    Front Vet Sci; 2024; 11():1423390. PubMed ID: 39113723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.
    Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW
    BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and Urinary Uromodulin in Dogs with Early Chronic Kidney Disease vs. Healthy Canine Population.
    Marečáková N; Kačírová J; Tóthová C; Maďari A; Maďar M; Kuricová M; Horňák S
    Animals (Basel); 2024 Jul; 14(14):. PubMed ID: 39061561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversy of klotho as a potential biomarker in chronic kidney disease.
    Yu LX; Li SS; Sha MY; Kong JW; Ye JM; Liu QF
    Front Pharmacol; 2022; 13():931746. PubMed ID: 36210812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
    Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Ruiz-Torres MP; Gómez-Alonso C; Rodríguez-García M; Fernández-Martín JL; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor-23 and Alpha-Klotho concentrations in dogs with canine Leishmaniasis.
    Gultekin G; Ulutas PA
    Res Vet Sci; 2024 May; 171():105234. PubMed ID: 38547738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease.
    Parker VJ; Rudinsky AJ; Benedict JA; Beizaei A; Chew DJ
    J Vet Intern Med; 2020 Nov; 34(6):2497-2506. PubMed ID: 33128421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of fibroblast growth factor-23 and soluble alpha klotho in different stages of chronic kidney disease.
    Khodeir SA; Okda HI; Abdalal HM
    Saudi J Kidney Dis Transpl; 2019; 30(1):108-118. PubMed ID: 30804272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
    Adema AY; de Roij van Zuijdewijn CLM; Hoenderop JG; de Borst MH; Ter Wee PM; Heijboer AC; Vervloet MG;
    BMC Nephrol; 2018 Nov; 19(1):327. PubMed ID: 30442108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
    Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.
    Martín-Vírgala J; Fernández-Villabrille S; Martín-Carro B; Tamargo-Gómez I; Navarro-González JF; Mora-Fernández C; Calleros L; Astudillo-Cortés E; Avello-Llano N; Mariño G; Dusso AS; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986200
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Pei Y; Miu M; Mao X; Chen W; Zhu J
    Int J Clin Pract; 2023; 2023():8244545. PubMed ID: 38187354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor alpha (TNFα) and alpha-Klotho (αKL) in children and adolescents with chronic kidney disease (CKD).
    Gamrot Z; Adamczyk P; Świętochowska E; Roszkowska-Bjanid D; Gamrot J; Szczepanska M
    Endokrynol Pol; 2021; 72(6):625-633. PubMed ID: 34647605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for anemia in the early stages of chronic kidney disease].
    Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV
    Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.
    Akimoto T; Yoshizawa H; Watanabe Y; Numata A; Yamazaki T; Takeshima E; Iwazu K; Komada T; Otani N; Morishita Y; Ito C; Shiizaki K; Ando Y; Muto S; Kuro-o M; Kusano E
    BMC Nephrol; 2012 Nov; 13():155. PubMed ID: 23176706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum α-Klotho Protein Can Be an Independent Predictive Marker of Oxidative Stress (OS) and Declining Glomerular Function Rate in Chronic Kidney Disease (CKD) Patients.
    Jena S; Sarangi P; Das UK; Lamare AA; Rattan R
    Cureus; 2022 Jun; 14(6):e25759. PubMed ID: 35812534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.